Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study.
Sebastian PodlipnikAram BoadaJose Luis López EstebaranzManuel M Martín-GonzálezPedro Redondo BellónBrian MartinAnn P QuickChristine N BaileySarah J KurleyRobert W CookSusana Puig SardàPublished in: Cancers (2022)
The 31-GEP is a significant predictor of disease relapse in patients with stage IB-II melanoma and accurately stratified patients by risk of relapse.